Healthcare -
Biotechnology - NASDAQ - US
$ 15.49
-7.91 %
$ 475 M
Market Cap
-2.56
P/E
ANAB - OTHER CURRENT LIABILITIES
Other Current Liabilities ANAB - AnaptysBio, Inc.
31 M
LAST VALUE
65.19%
2 YEAR CAGR
28.73%
5 YEAR CAGR
45.21%
10 YEAR CAGR